Paper213720
Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.
Glickman RM and 3 others. N Engl J Med, 1978. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. Papers, record 213720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/213720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apolipoproteins | Major topic |
| Hypolipoproteinemias | Major topic |
| Intestinal Mucosa | Major topic |
| Tangier Disease | Major topic |
| Biopsy | |
| C-Peptide | |
| Chylomicrons | |
| Dietary Fats | |
| Fluorescent Antibody Technique | |
| Humans | |
| Immunoelectrophoresis | |
| Jejunum | |
| Lipoproteins, HDL | |
| Male |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35918332 | Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35918332 | PubMed |
| 26828064 | Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26828064 | PubMed |
| 26368306 | Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26368306 | PubMed |
| 26226572 | Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice. | Gastroenterology | 2015 | https://conductscience.org/library/papers/26226572 | PubMed |
| 7430351 | A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7430351 | PubMed |
| 7204560 | Transport of apolipoproteins A-I and A-II by human thoracic duct lymph. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7204560 | PubMed |
| 7173298 | Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7173298 | PubMed |
| 7130397 | Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier). | J Clin Invest | 1982 | https://conductscience.org/library/papers/7130397 | PubMed |
| 6995467 | Detection of apolipoprotein C in human and rat enterocytes. | J Cell Biol | 1980 | https://conductscience.org/library/papers/6995467 | PubMed |
| 6987270 | Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6987270 | PubMed |
| 6750220 | [The apolipoproteins in man ]. | Klin Wochenschr | 1982 | https://conductscience.org/library/papers/6750220 | PubMed |
| 6412234 | Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6412234 | PubMed |
| 6294659 | Isolation and characterization of cDNA clones for human apolipoprotein A-I. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6294659 | PubMed |
| 3936741 | Determination of serum apo A-IV concentration in patients receiving total parenteral nutrition. | Gastroenterol Jpn | 1985 | https://conductscience.org/library/papers/3936741 | PubMed |
| 2846400 | Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis. | Gastroenterol Jpn | 1988 | https://conductscience.org/library/papers/2846400 | PubMed |
| 2475735 | Determination of HDL2 cholesterol by precipitation with dextran sulfate and magnesium chloride: establishing optimal conditions for rat plasma. | Lipids | 1989 | https://conductscience.org/library/papers/2475735 | PubMed |
| 225354 | Metabolic fate of chylomicron phospholipids and apoproteins in the rat. | J Clin Invest | 1979 | https://conductscience.org/library/papers/225354 | PubMed |
| 221544 | Human intestinal lipoproteins. Studies in chyluric subjects. | J Clin Invest | 1979 | https://conductscience.org/library/papers/221544 | PubMed |
| 221542 | Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat. | J Clin Invest | 1979 | https://conductscience.org/library/papers/221542 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOA1 | 335 | PubTator's text mining | https://conductscience.org/library/genes/335 | NCBI Gene |
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/213720
GET https://conductscience.org/api/papers/v1/213720/authors